Immunomodulation in Pancreatic Cancer

Immunomodulation in Pancreatic Cancer

Pancreatic cancer has a high mortality rate, and its incidence is increasing worldwide. The almost universal poor prognosis of pancreatic cancer is partly due to symptoms presenting only at late stages and limited effective treatments. Recently, immune checkpoint blockade inhibitors have drastically...

Full description

Bibliographic Details
Main Authors: Mithunah Krishnamoorthy, John G. Lenehan, Jeremy P. Burton, Saman Maleki Vareki
Format: Article
Language:English
Published: MDPI AG 2020-11-01
Series:Cancers
Subjects:
pancreatic cancer
pancreatic ductal carcinoma
immunotherapy
anti-PD1
microbiome
fecal microbiota transplant
Online Access:https://www.mdpi.com/2072-6694/12/11/3340

Internet

https://www.mdpi.com/2072-6694/12/11/3340

Similar Items